Table 1.

Summary of previously published data for anti-Aβ immunotherapy studies.

Study	Mouse model	Age (mo)	Histopathology			Cognition
			Aβ	CAA	Micro-hemorrhage
Passive immunization	APPSw	19-22	↓60%	↑ 4-fold	↑ 6-fold	Improved
Active vaccination	APPSw/ NOS2-/-	12-16	↓85%	No change	↑ 10-fold	Reversed